30 Day Trial

Aurora Spine Posts 3Q15 Revenue


Aurora Spine reported 3Q15 revenue of US $1.17MM, +116% vs. 3Q14. Sales of >640 units in 3Q15 represent an >25% increase sequentially vs. 2Q15. Ex-U.S. sales comprised ~7% of revenues. Aurora's sales effort is primarily focused on the U.S., and the company doubled its salesforce within 3Q15.

Sales of TiNano® interbody devices represented ~60% of revenue (~$0.7MM), with Discovery™ accounting for $0.34MM. ZIP® fusion devices posted >$0.36MM in sales. 

Other 3Q15 highlights include:


Source: Aurora Spine Corporation